2-hydroxydesipramine

Known as: 2-OH-DMI, 2-hydroxy-desipramine, 2-hydroxydesmethylimipramine 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1967-2016
024619672016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1993
1993
OBJECTIVE To assess the developmental effects of desipramine (DMI) treatment on the electrocardiogram (ECG), we investigated… (More)
Is this relevant?
1992
1992
Steady-state serum concentrations of desipramine (DMI) and its metabolite, 2-hydroxydesipramine (OHDMI), were measured in 40… (More)
Is this relevant?
1988
1988
We describe the relationship of 2-hydroxydesipramine (OH-DMI) plasma levels and response in a prospective DMI study in which… (More)
Is this relevant?
1987
1987
The 2-hydroxylation of desmethylimipramine (DMI) was studied in 14 healthy subjects previously phenotyped with respect to… (More)
Is this relevant?
1986
1986
Desipramine and its metabolite 2-hydroxydesipramine were measured in the milk of a nursing mother and in the plasma of the mother… (More)
Is this relevant?
1985
1985
Studies of the relationship between plasma concentrations of desipramine hydrochloride and clinical response have shown… (More)
Is this relevant?
1984
1984
Plasma levels of desipramine (DMI) and the unconjugated form of its principal metabolite 2-hydroxydesipramine (OH-D) were… (More)
Is this relevant?
1984
1984
The 2-hydroxylation of desmethylimipramine (DMI) and the 4-hydroxylation of debrisoquine (D) were studied in healthy subjects and… (More)
Is this relevant?
1983
1983
The clinical utility of 2-hydroxydesipramine (2-OH-DMI) measurements was evaluated by examining the relationship of 2-OH-DMI… (More)
Is this relevant?
1982
1982
Recent reports demonstrate that hydroxy metabolites of desipramine (DMI) have pharmacologic activity and do not just produce side… (More)
Is this relevant?